Below are the most recent publications written about "Carcinoma, Squamous Cell" by people in Profiles.
-
Zhu X, Meng X, Mochel MC, Wiliams EA, Dresser K, Tomaszewicz K, Hutchinson L, Bledsoe JR. CYLD-mutated anal squamous cell carcinoma: An uncommon entity associated with cylindroma-like morphology and adverse clinical features. Hum Pathol. 2025 Mar; 157:105765.
-
Brady JS, Norouzi A, Konuthula N, Lam A, Marchiano E, Futran N, Barber B. Examining the Impact of Race and Sex on the Incidence of Positive Surgical Margins in Oral Cavity Squamous Cell Carcinoma. Head Neck. 2025 May; 47(5):1512-1519.
-
Challapalli A, Stewart G, Shaw H, Davies PJ, Lopez-Baez JC, Ottley EC, Kelly S. Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab). Front Immunol. 2024; 15:1408667.
-
Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, Martin ACBM, do Nascimento Braga Pereira L, de Carvalho CEB, Crovador CS, de Paula FE, Nascimento FC, de Freitas HT, de Lima Vazquez V, Reis RM, da Silva-Oliveira RJ. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line. Hum Cell. 2024 Jul; 37(4):1170-1183.
-
Ortiz AE, Ahluwalia J, Anderson RR, Franco W, Brian Jiang SI. Autofluorescence Excitation Imaging of Nonmelanoma Skin Cancer for Margin Assessment Before Mohs Micrographic Surgery: A Pilot Study. Dermatol Surg. 2024 07 01; 50(7):616-619.
-
Cornejo KM, Hutchinson L, O'Donnell P, Meng X, Tomaszewicz K, Shalin SC, Cassarino DS, Chan MP, Quinn TR, Googe PB, Nazarian RM. Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations. Arch Pathol Lab Med. 2024 Feb 01; 148(2):215-222.
-
Hanna GJ, Dharanesswaran H, Giobbie-Hurder A, Harran JJ, Liao Z, Pai L, Tchekmedyian V, Ruiz ES, Waldman AH, Schmults CD, Riella LV, Lizotte P, Paweletz CP, Chandraker AK, Murakami N, Silk AW. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. J Clin Oncol. 2024 Mar 20; 42(9):1021-1030.
-
Massey PR, Wang DM, Murad F, Mulvaney P, Moore K, Okhovat JP, Russell-Goldman E, Lin WM, Piris A, Huilgol SC, Ruiz ES, Schmults CD. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis. JAMA Dermatol. 2023 12 01; 159(12):1332-1338.
-
Medeiros MC, The S, Bellile E, Russo N, Schmitd L, Danella E, Singh P, Banerjee R, Bassis C, Murphy GR, Sartor MA, Lombaert I, Schmidt TM, Eisbruch A, Murdoch-Kinch CA, Rozek L, Wolf GT, Li G, Chen GY, D'Silva NJ. Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer. Microbiome. 2023 Nov 30; 11(1):268.
-
Gupta N, Mulvaney PM, Murad F, Gastman BR, Ilori E, Koyfman S, Schmults CD, Vidimos AT, Ruiz ES. Improved homogeneity and monotonicity of American Joint Committee on Cancer staging manual, 8th edition on cutaneous squamous cell carcinoma with addition of poor differentiation. J Am Acad Dermatol. 2024 02; 90(2):423-425.